A carregar...
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
BACKGROUND & AIMS: In recent years, nonalcoholic steatohepatitis (NASH) has become a considerable healthcare burden worldwide. Pathogenesis of NASH is associated with type 2 diabetes mellitus (T2DM) and insulin resistance. However, a specific drug to treat NASH is lacking. We investigated the ef...
Na minha lista:
Publicado no: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4701474/ https://ncbi.nlm.nih.gov/pubmed/26731267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0146337 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|